Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohortsXiaowen Huang, Haoyan Chen, Xiaoqiang Zhu et al.|Cell Host & Microbe|2023Cited by 82
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s diseaseZhenyu Wang, Jie Hong, Tian Li et al.|Cell Metabolism|2025Cited by 30
Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailabilityYuqing Yan, Jie Hong, Zhenhua Wang et al.|Cell Reports Medicine|2023Cited by 22
Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotypeMuni Hu, Haoyan Chen, Xiaoqiang Zhu et al.|Cell Reports|2025Cited by 10
<i>Bacteroides fragilis</i> Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel DiseaseYuqing Yan, Jie Hong, Li Tian et al.|Journal of Crohn s and Colitis|2025Cited by 8